Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Former dairy farmer joins PBD Biotech’s fight against bovine TB

Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to take its Actiphage® blood test for bovine TB (bTB) and Johne’s Disease through the validation required for international industry acceptance.
  • May 26, 2021
  • Company, People
Jonnie Yewdall
Jonnie Yewdall

Jonnie has worked in a commercial role in other industries, but he knows first-hand the devastating impact bTB and Johne’s disease can have on farmers through his experiences on a family farm in North Devon, where the herd was decimated by these diseases.

He lost a third of his Guernsey herd following a positive bTB test, and then the replacement animals began to show signs of Johne’s Disease, another mycobacterial disease. Unfortunately, this was the final straw. The emotional toil and the ongoing financial loss were too great and the Yewdalls sold the family farm.

Jonnie says: “I think that Covid-19 has shown the wider business community what it is like to be a dairy farmer at risk from bTB – you are locked-down and you can’t plan or budget.

“I don’t want any farmers to go through what we did, which is why I have joined PBD Biotech. With tools like Actiphage the industry has an opportunity to work together to potentially eradicate these very difficult diseases.”

Actiphage is an extremely specific test, as it detects the DNA from live bacteria in a sample of blood or milk, not just the animal’s immune reaction. It can detect just a few cells; this enables farmers to identify carriers of the disease and remove them from the herd before they become spreaders. This was a recent recommendation from the cattle health certification standards regulatory body Checs.

Actiphage has been approved by APHA for use under special conditions, and when used on-farm as part of a disease management programme it has been proven to eradicate bovine TB.

By recently gaining £2.3M of funding, PBD Biotech is now able to take Actiphage through trials to gain OIE (the World Organisation for Animal Health) validation for the test which will enable international acceptance.

Jonnie sees potential for Actiphage to be used as part of a wider disease management programme to enable farmers to eradicate and then maintain a disease-free status on the farm.

“Actiphage is a blood test for live mycobacteria that gives you a simple yes/no answer. When this is authorised for use on the farm, we could use it in parallel with the statutory testing to manage the infection risk, for example isolating inconclusive reactors pending a further skin test,” he says.

“It could be used as a ‘pre-movement’ test to check animals before they are introduced into a herd and also as a ‘DIVA’ test to differentiate infected from vaccinated animals, paving the way for the introduction of a vaccination programme.”

Share:

Related posts

Loading...
global unmet need for rapid molecular diagnostic for human TB

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023
PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis (TB) and will be suspending its commercial Johne’s Testing Service.
global unmet need for rapid molecular diagnostic for human TB

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023
PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis...
Marie Roskrow

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023
Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need, PBD Biotech is announcing that it has appointed Dr Marie Roskrow to chair its board and has expanded its scientific...
Marie Roskrow

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023
Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need,...
Pictured from left are Ray Harris from Foresight, Sandy Reid of Mercia Asset Management, Jane Theaker of PBD Biotech and Mark Wilcockson of British Business Bank

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022
Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic with potential to revolutionise management of TB.
Pictured from left are Ray Harris from Foresight, Sandy Reid of Mercia Asset Management, Jane Theaker of PBD Biotech and Mark Wilcockson of British Business Bank

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022
Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic...
Mondana Cook, Chief Operating Officer at PBD Biotech

Mondana Cook joins PBD Biotech to bring human TB diagnostic to market

July 19, 2022
New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine.
Mondana Cook, Chief Operating Officer at PBD Biotech

Mondana Cook joins PBD Biotech to bring human TB diagnostic to market

July 19, 2022
New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine.
1 2 … 6 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More